Education
About Us
Working with TipRanks
Follow Us
BioNTech SE (BNTX)
NASDAQ:BNTX
Total Valuation
BioNTech SE has a market cap or net worth of $26.72B. The enterprise value is ―.
Market Cap$26.72B
Enterprise Value―
Share Statistics
BioNTech SE has 240,392,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding240,392,620
Owned by Insiders0.49%
Owned by Institutions13.11%
Financial Efficiency
BioNTech SE’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -6.44%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-6.44%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee406.25K
Profits Per Employee-100.07K
Employee Count6,772
Asset Turnover0.12
Inventory Turnover1.91
Valuation Ratios
The current PE Ratio of BioNTech SE is -39.76. BioNTech SE’s PEG ratio is 0.79.
PE Ratio-39.76
PS Ratio0.00
PB Ratio1.09
Price to Fair Value1.36
Price to FCF-100.16
Price to Operating Cash Flow86.95
PEG Ratio0.79
Income Statement
In the last 12 months, BioNTech SE had revenue of 2.75B and earned -665.30M in profits. Earnings per share was -2.77.
Revenue2.75B
Gross Profit2.21B
Operating Income-1.31B
Pretax Income-677.70M
Net Income-665.30M
EBITDA-367.10M
Earnings Per Share (EPS)-2.77
Cash Flow
In the last 12 months, operating cash flow was 242.24M and capital expenditures -452.27M, giving a free cash flow of -210.02M billion.
Operating Cash Flow242.24M
Free Cash Flow-210.02M
Free Cash Flow per Share-0.87
Dividends & Yields
BioNTech SE pays an annual dividend of $1.534, resulting in a dividend yield of ―
Dividend Per Share$1.534
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change9.78%
50-Day Moving Average98.87
200-Day Moving Average108.23
Relative Strength Index (RSI)59.29
Average Volume (3m)1.38M
Important Dates
BioNTech SE upcoming earnings date is Aug 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 5, 2025
Next Earnings DateAug 4, 2025
Ex-Dividend DateJun 02, 2022
Financial Position
BioNTech SE as a current ratio of 7.45, with Debt / Equity ratio of 1.31%
Current Ratio7.45
Quick Ratio7.34
Debt to Market Cap<0.01
Net Debt to EBITDA25.90
Interest Coverage Ratio-104.31
Taxes
In the past 12 months, BioNTech SE has paid -12.40M in taxes.
Income Tax-12.40M
Effective Tax Rate0.02
Enterprise Valuation
BioNTech SE EV to EBITDA ratio is -46.16, with an EV/FCF ratio of -69.28.
EV to Sales6.16
EV to EBITDA-46.16
EV to Free Cash Flow-69.28
EV to Operating Cash Flow81.59
Balance Sheet
BioNTech SE has $16.78B in cash and marketable securities with €254.20M in debt, giving a net cash position of -$16.53B billion.
Cash & Marketable Securities$16.78B
Total Debt€254.20M
Net Cash-$16.53B
Net Cash Per Share-$68.76
Tangible Book Value Per Share$75.87
Margins
Gross margin is 80.28%, with operating margin of -47.77%, and net profit margin of -24.18%.
Gross Margin80.28%
Operating Margin-47.77%
Pretax Margin-24.63%
Net Profit Margin-24.18%
EBITDA Margin-13.34%
EBIT Margin-24.18%
Analyst Forecast
The average price target for BioNTech SE is $140.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$140.00
Price Target Upside27.10% Upside
Analyst ConsensusModerate Buy
Analyst Count19
Revenue Growth Forecast0.58%
EPS Growth Forecast-764.64%